New Results
Oxamniquine Derivatives Overcome Praziquantel Treatment Limitations for Schistosomiasis
View ORCID ProfileSevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Michael Tidwell, Stanton F. McHardy, View ORCID ProfilePhilip T. LoVerde
doi: https://doi.org/10.1101/2023.05.23.541778
Sevan N. Alwan
1Departments of Biochemistry and Structural Biology, University of Texas Health at San Antonio; San Antonio, Texas 78229, USA
Alexander B. Taylor
2Biology Core Facilities, University of Texas Health at San Antonio; San Antonio, Texas 78229, USA
Jayce Rhodes
3Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio; San Antonio, Texas 78249, USA
Michael Tidwell
3Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio; San Antonio, Texas 78249, USA
Stanton F. McHardy
3Center for Innovative Drug Discovery, Department of Chemistry, University of Texas at San Antonio; San Antonio, Texas 78249, USA
Philip T. LoVerde
1Departments of Biochemistry and Structural Biology, University of Texas Health at San Antonio; San Antonio, Texas 78229, USA
Posted May 23, 2023.
Oxamniquine Derivatives Overcome Praziquantel Treatment Limitations for Schistosomiasis
Sevan N. Alwan, Alexander B. Taylor, Jayce Rhodes, Michael Tidwell, Stanton F. McHardy, Philip T. LoVerde
bioRxiv 2023.05.23.541778; doi: https://doi.org/10.1101/2023.05.23.541778
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)